[Congressional Record Volume 168, Number 121 (Thursday, July 21, 2022)]
[Senate]
[Pages S3581-S3583]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
LEGISLATIVE SESSION
______
CHIPS ACT OF 2022--Resumed
The ACTING PRESIDENT pro tempore. Under the previous order, the
Senate will resume consideration of the House message to accompany H.R.
4346, which the clerk will report.
The senior assistant legislative clerk read as follows:
House message to accompany H.R. 4346, a bill making
appropriations for Legislative Branch for the fiscal year
ending September 30, 2022, and for other purposes.
Pending:
Schumer motion to concur in the amendment of the House to
the amendment of the Senate to the bill, with Schumer
Amendment No. 5135 (to the House amendment to the Senate
amendment), relating to the CHIPS Act of 2022.
Schumer Amendment No. 5136 (to Amendment No. 5135), to add
an effective date.
Schumer motion to refer the bill to the Committee on
Commerce, Science, and Transportation, with instructions,
Schumer Amendment No. 5137, to add an effective date.
Schumer Amendment No. 5138 (to (the instructions) Amendment
No. 5137), to modify the effective date.
Recognition of the Majority Leader
The ACTING PRESIDENT pro tempore. The Democratic leader is
recognized.
Cannabis Administration and Opportunity Act
Mr. SCHUMER. Madam President, over the last few decades, Americans'
views on cannabis legalization have dramatically, dramatically changed.
Twenty years ago, less than a third of Americans believed that cannabis
should be made legal. Today, that share is nearly 70 percent of the
population, the highest level of support ever.
We can see this shift playing out in the States. Nearly 90 percent of
Americans live in a State that has legalized cannabis for either
medical or adult recreational use. New York legalized cannabis in 2021.
And even voters in deep-red South Dakota voted to legalize it for adult
recreational use.
Cannabis legalization has proven immensely successful at the State
level so it is time that Congress catches up with the rest of the
country.
Last year, Senators Wyden, Booker, and I released a discussion draft
of the Cannabis Administration and Opportunity Act. After receiving
more than 1,800 public comments and working with numerous Senate
committees to improve the bill, today we are introducing this historic
legislation.
I am proud to be the first majority leader ever to say that it is
time to end the Federal prohibition on cannabis, and this bill provides
the best framework for updating our cannabis laws and reversing decades
of harm inflicted by the War on Drugs.
I have had many productive conversations with my Republican and
Democratic colleagues about cannabis reform, and I look forward to
working with Members from both sides of the aisle to secure support for
this bill.
Our bill will legalize cannabis by removing it from the Controlled
Substances Act, empowering States to create their own cannabis laws
instead. It
[[Page S3582]]
will establish a robust regulatory system to protect public health and
ensure that cannabis is as safe as possible. It includes rules to
prevent impaired driving, prevent youth access, and prevent illegal
diversion. We also robustly fund a variety of research programs to make
up for lost time when it comes to cannabis research.
So important, our bill will also expunge the Federal criminal records
of people with convictions for nonviolent cannabis offenses and allow
those in Federal prison for nonviolent cannabis offenses to appeal
their sentences.
It is a tragedy--tragedy--that far too many Americans, particularly
Black and Hispanic Americans, have permanent blocks on their record,
making it nearly impossible to move forward with their lives just
because they were arrested with a little marijuana in their pocket. How
unfair and what a waste of human resources.
Our bill will also establish an Opportunity Trust Fund to reinvest in
communities that have been devastated by the War on Drugs. And it will
create opportunities for entrepreneurs and small businesses to
legitimately pursue new opportunities in the growing cannabis industry.
And, of course, underlying it all, this bill is about individual
freedom and basic fairness. The fact that cannabis remains a schedule I
controlled substance--in the same bad company of other drugs like
heroin--is not just senseless; it is deeply harmful for countless
Americans--again, almost always people of color--and it impinges on the
freedom of all of us. If this is working in all the States, why not let
people use it?
We need to change that. We need to change the lack of freedom and
fairness. We need to create opportunities for entrepreneurs to
legitimately pursue new opportunities, and comprehensive Federal
cannabis legislation is critical to reaching that goal.
I want to extend my deep appreciation to Senators Booker and Wyden as
well as all of my colleagues who have worked with us on this important
and long-overdue change. I want to thank Senators Murray and Senator
Peters and all the chairs of the more than 10 Senate committees who
worked with us over the past several years to significantly improve the
bill from the discussion draft we released last year. This bill would
not be possible without the hard work of them and their staffs.
I want to stress that this is the beginning of the legislative
process, not the end. We are going to work hard to create support for
our bill, and I hope we can make more progress toward cannabis reform
in the future. I look forward to working with Democrats and Republicans
to get something done this year.
H.R. 4346
Madam President, now on the chips bill, last night, I filed cloture
on a major piece of legislation that will help lower costs, boost
scientific innovation, and take direct aim at the national chips
shortage, which is hurting almost every single American.
Members of both sides know that America's chips crisis is sending
shock waves across the economy. It is endangering our national
security. According to an article by Bloomberg, China's top chipsmaker
has now likely advanced its tech by two generations, threatening U.S.
competitiveness.
To ignore the chips crisis means higher costs, squandered job
opportunities, and greater dependence on foreign chip producers.
Thankfully, the Senate is close to finally taking action.
In the long run, our bipartisan chips bill will ease semiconductor
supply chain woes, increase domestic inventory of chips, and thus help
lower costs on all sorts of products that rely on chips to work.
But because the vote earlier this week was so bipartisan, I amended
the bill to include one of the largest science packages the Senate has
considered in a long time.
As you know, I was the original author of many of the provisions in
the science section when I worked with Senator Young on the Endless
Frontier Act more than 2 years ago.
We will devote tens of billions of dollars to cultivate the next
generation of tech hubs all across the country, especially in regions
that have been overlooked. We will invest in new science jobs, and that
will keep America No. 1. It has always been America's cutting-edge lead
on innovation, in science and research, that has then created millions
and millions of good-paying jobs and kept our economy prosperous. In
the last decade, America seems to have forgotten that, and this bill
revitalizes that goal and that dream.
These scientific investments are crucial not just for innovation and
science jobs but for critical jobs that support these industries too.
I will keep working with my colleagues to get this bill done quickly.
With 64 votes in favor of moving forward earlier this week, there is no
reason to wait around.
The 21st century will be won or lost on the battleground of
technological innovation. Let me say it again because that is a crucial
sentence. The 21st century will be won or lost on the battleground of
technological innovation.
Our country now faces a moment of truth: Will American workers,
American tech, and American ingenuity shape the world over the next
hundred years in the same way we have shaped it in the last hundred? Of
course, I believe America will lead the way if this Chamber is willing
to do what is necessary for our economic and national security.
Prescription Drug Costs
Madam President, now on prescription drugs, later today, Senate
Democrats and Republicans will meet with the Parliamentarian to start
the so-called Byrd bath on legislation to bring down the cost of
prescription drugs, cap out-of-pocket expenses, and make sure millions
of Americans do not see their premiums go up in the coming months. This
is an important step in the larger process of bringing a reconciliation
bill to the floor that can win the support of all 50 Democratic
Senators.
Ask any American on the street, and it is a guarantee that they will
agree the price of prescription medications is one of the most
frustrating and debilitating problems in our country.
It is a vicious pincer grip: On the one hand, Americans desperately
need their medicines to stay healthy, live a normal life, and stay
alive, in some cases, but on the other hand, that means many Americans
have to pay an arm and a leg at the pharmacy just to stay healthy.
Meanwhile, as Americans pay exorbitant prices for basic medications,
the Nation's largest pharmaceutical companies are feasting off record
profits because they face little accountability for jacking up prices
to consumers. This cannot continue.
Democrats are going to work in the weeks ahead on legislation that
will empower Medicare to negotiate the price of prescription drugs for
the first time ever. We will also cap out-of-pocket expenses at $2,000
a year. These changes will save Americans an incredible amount of
money, and it is one of the best things we can do to lower costs for
the American people.
Let me say again, lowering the cost of prescription drugs and capping
out-of-pocket expenses is one of the very best things we can do to
fight inflation and lower costs for the American people. So those who
talk about inflation, support this bill.
So in the coming weeks, the question before the Senate will be
simple: Who will take action in this Chamber to bring down the cost of
prescription drugs and make sure premiums don't go up in the future,
and who will defend the interests of Big Pharma that spikes the prices
of scores of crucial drugs?
Tucker Carlson
Madam President, finally, on FOX News, earlier this week, FOX News
anchor Tucker Carlson once again used his enormous platform on prime-
time television to spread the malicious, dangerous, and racist
conspiracy of ``replacement theory.'' It is far from the first time he
has done so. But in light of the recent violence in Buffalo inspired by
``replacement theory,'' it is shocking and dangerous for Mr. Carlson to
keep propagating this message.
I am deeply disappointed--frankly, outraged--that FOX News has taken
no action to address the conduct of Mr. Carlson. It makes me sick to my
stomach to think that Mr. Carlson has been given a free pass to amplify
racist conspiracy theories to millions of Americans--theories that are
eerily similar to those cited by Buffalo's horrible shooter.
[[Page S3583]]
There is only one way to describe what Mr. Carlson is doing: He is
stoking racial resentment among his viewers with these vile and racist
conspiracy theories. I urge FOX News to compel him to stop at once.
____________________